Literature DB >> 36029479

SLOAD: a comprehensive database of cancer-specific synthetic lethal interactions for precision cancer therapy via multi-omics analysis.

Li Guo1, Yuyang Dou1, Daoliang Xia1, Zibo Yin1, Yangyang Xiang1, Lulu Luo2, Yuting Zhang1, Jun Wang1, Tingming Liang2.   

Abstract

Synthetic lethality has been widely concerned because of its potential role in cancer treatment, which can be harnessed to selectively kill cancer cells via identifying inactive genes in a specific cancer type and further targeting the corresponding synthetic lethal partners. Herein, to obtain cancer-specific synthetic lethal interactions, we aimed to predict genetic interactions via a pan-cancer analysis from multiple molecular levels using random forest and then develop a user-friendly database. First, based on collected public gene pairs with synthetic lethal interactions, candidate gene pairs were analyzed via integrating multi-omics data, mainly including DNA mutation, copy number variation, methylation and mRNA expression data. Then, integrated features were used to predict cancer-specific synthetic lethal interactions using random forest. Finally, SLOAD (http://www.tmliang.cn/SLOAD) was constructed via integrating these findings, which was a user-friendly database for data searching, browsing, downloading and analyzing. These results can provide candidate cancer-specific synthetic lethal interactions, which will contribute to drug designing in cancer treatment that can promote therapy strategies based on the principle of synthetic lethality. Database URL http://www.tmliang.cn/SLOAD/.
© The Author(s) 2022. Published by Oxford University Press.

Entities:  

Mesh:

Year:  2022        PMID: 36029479      PMCID: PMC9419874          DOI: 10.1093/database/baac075

Source DB:  PubMed          Journal:  Database (Oxford)        ISSN: 1758-0463            Impact factor:   4.462


  47 in total

Review 1.  Synthetic lethality and cancer therapy: lessons learned from the development of PARP inhibitors.

Authors:  Christopher J Lord; Andrew N J Tutt; Alan Ashworth
Journal:  Annu Rev Med       Date:  2014-10-17       Impact factor: 13.739

Review 2.  Integrating genetic approaches into the discovery of anticancer drugs.

Authors:  L H Hartwell; P Szankasi; C J Roberts; A W Murray; S H Friend
Journal:  Science       Date:  1997-11-07       Impact factor: 47.728

Review 3.  Development of Olaparib for BRCA-Deficient Recurrent Epithelial Ovarian Cancer.

Authors:  Krishnansu S Tewari; Ramez N Eskander; Bradley J Monk
Journal:  Clin Cancer Res       Date:  2015-07-13       Impact factor: 12.531

4.  The Genotype-Tissue Expression (GTEx) project.

Authors: 
Journal:  Nat Genet       Date:  2013-06       Impact factor: 38.330

5.  Predicting selective drug targets in cancer through metabolic networks.

Authors:  Ori Folger; Livnat Jerby; Christian Frezza; Eyal Gottlieb; Eytan Ruppin; Tomer Shlomi
Journal:  Mol Syst Biol       Date:  2011-06-21       Impact factor: 11.429

6.  A global analysis of genetic interactions in Caenorhabditis elegans.

Authors:  Alexandra B Byrne; Matthew T Weirauch; Victoria Wong; Martina Koeva; Scott J Dixon; Joshua M Stuart; Peter J Roy
Journal:  J Biol       Date:  2007-09-26

7.  TCGAbiolinks: an R/Bioconductor package for integrative analysis of TCGA data.

Authors:  Antonio Colaprico; Tiago C Silva; Catharina Olsen; Luciano Garofano; Claudia Cava; Davide Garolini; Thais S Sabedot; Tathiane M Malta; Stefano M Pagnotta; Isabella Castiglioni; Michele Ceccarelli; Gianluca Bontempi; Houtan Noushmehr
Journal:  Nucleic Acids Res       Date:  2015-12-23       Impact factor: 16.971

8.  Cancer-Specific Synthetic Lethality between ATR and CHK1 Kinase Activities.

Authors:  Kumar Sanjiv; Anna Hagenkort; José Manuel Calderón-Montaño; Tobias Koolmeister; Philip M Reaper; Oliver Mortusewicz; Sylvain A Jacques; Raoul V Kuiper; Niklas Schultz; Martin Scobie; Peter A Charlton; John R Pollard; Ulrika Warpman Berglund; Mikael Altun; Thomas Helleday
Journal:  Cell Rep       Date:  2015-12-31       Impact factor: 9.423

9.  Systematic discovery of mutation-specific synthetic lethals by mining pan-cancer human primary tumor data.

Authors:  Subarna Sinha; Daniel Thomas; Steven Chan; Yang Gao; Diede Brunen; Damoun Torabi; Andreas Reinisch; David Hernandez; Andy Chan; Erinn B Rankin; Rene Bernards; Ravindra Majeti; David L Dill
Journal:  Nat Commun       Date:  2017-05-31       Impact factor: 14.919

10.  KG4SL: knowledge graph neural network for synthetic lethality prediction in human cancers.

Authors:  Shike Wang; Fan Xu; Yunyang Li; Jie Wang; Ke Zhang; Yong Liu; Min Wu; Jie Zheng
Journal:  Bioinformatics       Date:  2021-07-12       Impact factor: 6.937

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.